
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang, Li Zhou, Na Xie, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 430
Zhe Zhang, Li Zhou, Na Xie, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 430
Showing 1-25 of 430 citing articles:
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Molecular Therapy (2020) Vol. 28, Iss. 11, pp. 2320-2339
Open Access | Times Cited: 294
Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Molecular Therapy (2020) Vol. 28, Iss. 11, pp. 2320-2339
Open Access | Times Cited: 294
Ivermectin: An Anthelmintic, an Insecticide, and Much More
Richard J. Martin, Alan P. Robertson, Shivani Choudhary
Trends in Parasitology (2020) Vol. 37, Iss. 1, pp. 48-64
Open Access | Times Cited: 146
Richard J. Martin, Alan P. Robertson, Shivani Choudhary
Trends in Parasitology (2020) Vol. 37, Iss. 1, pp. 48-64
Open Access | Times Cited: 146
Multifunctional nanoparticle-mediated combining therapy for human diseases
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 125
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 125
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Ping Jin, Jingwen Jiang, Li Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 122
Ping Jin, Jingwen Jiang, Li Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 122
Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 107
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 107
Phytochemicals as a Complement to Cancer Chemotherapy: Pharmacological Modulation of the Autophagy-Apoptosis Pathway
Md. Ataur Rahman, Md. Abdul Hannan, Raju Dash, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 104
Md. Ataur Rahman, Md. Abdul Hannan, Raju Dash, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 104
Recent advances and limitations of mTOR inhibitors in the treatment of cancer
Eunüs S. Ali, Kangkana Mitra, Shamima Akter, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 103
Eunüs S. Ali, Kangkana Mitra, Shamima Akter, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 103
Deep learning for drug repurposing: Methods, databases, and applications
Xiaoqin Pan, Xuan Lin, Dongsheng Cao, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 98
Xiaoqin Pan, Xuan Lin, Dongsheng Cao, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 98
Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 91
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 91
Polymeric Micellar Systems—A Special Emphasis on “Smart” Drug Delivery
Irina Neguț, Bogdan Biță
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 976-976
Open Access | Times Cited: 81
Irina Neguț, Bogdan Biță
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 976-976
Open Access | Times Cited: 81
Recent advances in developing polymeric micelles for treating cancer: Breakthroughs and bottlenecks in their clinical translation
Jaskiran Kaur, Monica Gulati, Niraj Kumar Jha, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 5, pp. 1495-1512
Closed Access | Times Cited: 70
Jaskiran Kaur, Monica Gulati, Niraj Kumar Jha, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 5, pp. 1495-1512
Closed Access | Times Cited: 70
Functionalized nanoparticles: Tailoring properties through surface energetics and coordination chemistry for advanced biomedical applications
Yogendra Kumar, Amit Sinha, K.D.P. Nigam, et al.
Nanoscale (2023) Vol. 15, Iss. 13, pp. 6075-6104
Closed Access | Times Cited: 48
Yogendra Kumar, Amit Sinha, K.D.P. Nigam, et al.
Nanoscale (2023) Vol. 15, Iss. 13, pp. 6075-6104
Closed Access | Times Cited: 48
HGTDR: Advancing drug repurposing with heterogeneous graph transformers
Ali Gharizadeh, Karim Abbasi, Amin Ghareyazi, et al.
Bioinformatics (2024) Vol. 40, Iss. 7
Open Access | Times Cited: 18
Ali Gharizadeh, Karim Abbasi, Amin Ghareyazi, et al.
Bioinformatics (2024) Vol. 40, Iss. 7
Open Access | Times Cited: 18
Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens
Yao Lu, Qingqing Pan, Wenxia Gao, et al.
Biomaterials (2021) Vol. 281, pp. 121335-121335
Closed Access | Times Cited: 95
Yao Lu, Qingqing Pan, Wenxia Gao, et al.
Biomaterials (2021) Vol. 281, pp. 121335-121335
Closed Access | Times Cited: 95
Structural characterization and antitumor activity of a polysaccharide from Dendrobium wardianum
Guangying Ye, Jie Li, Jinhui Zhang, et al.
Carbohydrate Polymers (2021) Vol. 269, pp. 118253-118253
Closed Access | Times Cited: 93
Guangying Ye, Jie Li, Jinhui Zhang, et al.
Carbohydrate Polymers (2021) Vol. 269, pp. 118253-118253
Closed Access | Times Cited: 93
In vitro anticancer activity of Eclipta alba whole plant extract on colon cancer cell HCT-116
Vinod K. Nelson, Nalini Kanta Sahoo, Madhusmita Sahu, et al.
BMC Complementary Medicine and Therapies (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 89
Vinod K. Nelson, Nalini Kanta Sahoo, Madhusmita Sahu, et al.
BMC Complementary Medicine and Therapies (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 89
Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges
Jonaid Ahmad Malik, Sakeel Ahmed, Bisma Jan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112375-112375
Open Access | Times Cited: 76
Jonaid Ahmad Malik, Sakeel Ahmed, Bisma Jan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112375-112375
Open Access | Times Cited: 76
Druggable genome and precision medicine in cancer: current challenges
Camille Dupont, Kristina Riegel, Malvika Pompaiah, et al.
FEBS Journal (2021) Vol. 288, Iss. 21, pp. 6142-6158
Open Access | Times Cited: 69
Camille Dupont, Kristina Riegel, Malvika Pompaiah, et al.
FEBS Journal (2021) Vol. 288, Iss. 21, pp. 6142-6158
Open Access | Times Cited: 69
Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy
Zhe Zhang, Siyuan Qin, Yan Chen, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 2
Open Access | Times Cited: 69
Zhe Zhang, Siyuan Qin, Yan Chen, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 2
Open Access | Times Cited: 69
Cubosomes in cancer drug delivery: A review
Ryan Varghese, Sahil Salvi, Purab Sood, et al.
Colloids and Interface Science Communications (2021) Vol. 46, pp. 100561-100561
Open Access | Times Cited: 58
Ryan Varghese, Sahil Salvi, Purab Sood, et al.
Colloids and Interface Science Communications (2021) Vol. 46, pp. 100561-100561
Open Access | Times Cited: 58
Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges
Popat Kumbhar, Arehalli S. Manjappa, Rohit Shah, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 1-15
Closed Access | Times Cited: 56
Popat Kumbhar, Arehalli S. Manjappa, Rohit Shah, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 1-15
Closed Access | Times Cited: 56
Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 39
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 39
Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
Jieun Han, Jaesung Lim, Chi‐Pin James Wang, et al.
Nano Convergence (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 39
Jieun Han, Jaesung Lim, Chi‐Pin James Wang, et al.
Nano Convergence (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 39
A systematic review of computational approaches to understand cancer biology for informed drug repurposing
Faheem Ahmed, Anupama Samantasinghar, Afaque Manzoor Soomro, et al.
Journal of Biomedical Informatics (2023) Vol. 142, pp. 104373-104373
Open Access | Times Cited: 34
Faheem Ahmed, Anupama Samantasinghar, Afaque Manzoor Soomro, et al.
Journal of Biomedical Informatics (2023) Vol. 142, pp. 104373-104373
Open Access | Times Cited: 34
Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
Divya Ajmeera, Rajanna Ajumeera
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 148-175
Open Access | Times Cited: 33
Divya Ajmeera, Rajanna Ajumeera
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 148-175
Open Access | Times Cited: 33